BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 29924680)

  • 1. Immunological examination of peripheral blood in patients with colorectal cancer compared to healthy controls.
    Spacek J; Vocka M; Netikova I; Skalova H; Dundr P; Konopasek B; Zavadova E; Lubos P
    Immunol Invest; 2018 Oct; 47(7):643-653. PubMed ID: 29924680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Changes of lymphocyte subsets in peripheral blood of patients with hepatitis C].
    Wan H; Li Y; Yang N; Yuan W; Xie N; Wang D; Guo T; Mao Y
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Oct; 30(10):1058-61. PubMed ID: 25270208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue.
    Chaput N; Louafi S; Bardier A; Charlotte F; Vaillant JC; Ménégaux F; Rosenzwajg M; Lemoine F; Klatzmann D; Taieb J
    Gut; 2009 Apr; 58(4):520-9. PubMed ID: 19022917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reference ranges of lymphocyte subsets in healthy adults and adolescents with special mention of T cell maturation subsets in adults of South Florida.
    Valiathan R; Deeb K; Diamante M; Ashman M; Sachdeva N; Asthana D
    Immunobiology; 2014 Jul; 219(7):487-96. PubMed ID: 24661720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative immunophenotypic features of EBV-positive and EBV-negative atypical lymphocytosis.
    Hudnall SD; Patel J; Schwab H; Martinez J
    Cytometry B Clin Cytom; 2003 Sep; 55(1):22-8. PubMed ID: 12949956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flow cytometric characterization of human umbilical cord blood lymphocytes: immunophenotypic features.
    D'Arena G; Musto P; Cascavilla N; Di Giorgio G; Fusilli S; Zendoli F; Carotenuto M
    Haematologica; 1998 Mar; 83(3):197-203. PubMed ID: 9573672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in circulating lymphocyte subpopulations among patients with inflammatory polyps, colorectal adenomas and colorectal cancer.
    Zheng J; Jin H; Tu Y
    Arab J Gastroenterol; 2024 May; 25(2):129-134. PubMed ID: 38413325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of tumor burden on differentiation of T lymphocytes in the peripheral blood of patients with colorectal cancer].
    Cui M; Wang S; Ye YJ; Cui ZR; Ke Y
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(1):16-9. PubMed ID: 17403305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The importance of T-lymphocyte subsets on overall survival of colorectal and gastric cancer patients.
    Milasiene V; Stratilatovas E; Norkiene V
    Medicina (Kaunas); 2007; 43(7):548-54. PubMed ID: 17768369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulatory T cells, interleukin (IL)-6, IL-8, vascular endothelial growth factor (VEGF), CXCL10, CXCL11, epidermal growth factor (EGF) and hepatocyte growth factor (HGF) as surrogate markers of host immunity in patients with renal cell carcinoma.
    Polimeno M; Napolitano M; Costantini S; Portella L; Esposito A; Capone F; Guerriero E; Trotta A; Zanotta S; Pucci L; Longo N; Perdonà S; Pignata S; Castello G; Scala S
    BJU Int; 2013 Sep; 112(5):686-96. PubMed ID: 23495770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B7-H4 overexpression impairs the immune response of T cells in human cervical carcinomas.
    Wang X; Wang T; Xu M; Xiao L; Luo Y; Huang W; Zhang Y; Geng W
    Hum Immunol; 2014 Dec; 75(12):1203-9. PubMed ID: 25446402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of Blood T-Cells to Intratumoural Density and Location of CD3
    Hagland HR; Lea D; Watson MM; Søreide K
    Anticancer Res; 2017 Feb; 37(2):675-683. PubMed ID: 28179316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating Leukocyte Alterations and the Development/Progression of Diabetic Retinopathy in Type 1 Diabetic Patients - A Pilot Study.
    Obasanmi G; Lois N; Armstrong D; Lavery NJ; Hombrebueno JR; Lynch A; Wright DM; Chen M; Xu H
    Curr Eye Res; 2020 Sep; 45(9):1144-1154. PubMed ID: 31997663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of Fas antigen (CD95) in peripheral blood lymphocytes and in liver-infiltrating, cytotoxic lymphocytes in patients with hepatocellular carcinoma.
    Yuen MF; Hughes RD; Heneghan MA; Langley PG; Norris S
    Cancer; 2001 Oct; 92(8):2136-41. PubMed ID: 11596030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of blood T-lymphocyte subpopulations involved in host cellular immunity in dogs with mammary cancer.
    Karayannopoulou M; Anagnostou T; Margariti A; Kostakis C; Kritsepi-Konstantinou M; Psalla D; Savvas I
    Vet Immunol Immunopathol; 2017 Apr; 186():45-50. PubMed ID: 28413049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of bariatric surgery on peripheral blood lymphocyte subsets in women.
    Merhi ZO; Durkin HG; Feldman J; Macura J; Rodriguez C; Minkoff H
    Surg Obes Relat Dis; 2009; 5(2):165-71. PubMed ID: 18996763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [An analysis of immunophenotyping of peripheral lymphocytes in adult patients with infectious mononucleosis and chronic active Epstein-Barr virus infection].
    Xie J; Wang HL; Qiu ZF; Li TS
    Zhonghua Nei Ke Za Zhi; 2016 Jun; 55(6):455-9. PubMed ID: 27256608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic significance of peripheral T-lymphocyte subsets and natural killer cells in patients with colorectal cancer.
    Qiu H; Xiao-Jun W; Zhi-Wei Z; Gong C; Guo-Qiang W; Li-Yi Z; Yuan-Fang L; Rajiv-Prasad K
    Hepatogastroenterology; 2009; 56(94-95):1310-5. PubMed ID: 19950782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of irinotecan on the phenotype of peripheral blood leukocyte populations in patients with metastatic colorectal cancer.
    Melichar B; Touskova M; Vesely P
    Hepatogastroenterology; 2002; 49(46):967-70. PubMed ID: 12143255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Artesunate down-regulates immunosuppression from colorectal cancer Colon26 and RKO cells in vitro by decreasing transforming growth factor β1 and interleukin-10.
    Cui C; Feng H; Shi X; Wang Y; Feng Z; Liu J; Han Z; Fu J; Fu Z; Tong H
    Int Immunopharmacol; 2015 Jul; 27(1):110-21. PubMed ID: 25978851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.